GlassScriptPhysician profile
Harold C Agbahiwe
NPI 1073797460
$6,676.28
in general payments reported to CMS, 2019-2025
12 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,955 · 2020: $38.07 · 2022: $19.24 · 2023: $212 · 2024: $250 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $4,943.47 | 2019-2020 | |
| Astrazeneca Uk Limited | $1,050.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $207.81 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $163.58 | 2023-2024 | Myrisk |
| Incyte Corporation | $67.87 | 2023-2025 | Monjuvi, Jakafi, Pemazyre |
| Astrazeneca Pharmaceuticals LP | $61.45 | 2024-2025 | Imfinzi |
| Janssen Biotech, INC. | $51.08 | 2023 | Darzalex, Tecvayli |
| Merck Sharp & Dohme LLC | $39.95 | 2023 | Keytruda, Lynparza |
| Pharmaessentia USA Corporation | $28.00 | 2025 | Besremi |
| Bayer Healthcare Pharmaceuticals INC. | $22.78 | 2025 | |
| Alexion Pharmaceuticals, INC. | $21.05 | 2023 | Ultomiris |
| Palette Life Sciences, INC. | $19.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Agbahiwe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.